GLP-1 receptor agonists may benefit patients who have asthma, suggests new research published in the American Journal of Respiratory and Critical Care Medicine.

New research published in JAMA Network shows that nationwide naloxone prescriptions declined at the start of the pandemic and have yet to reach pre-pandemic levels.

FDA reminded health care professionals and the public that results from currently authorized COVID-19 antibody tests should not be used to assess a person’s level of immunity or protection from COVID-19 at any time, particularly after the person has received a COVID-19 vaccination.

In This Issue

May–June 2021

Finding connection in a virtual world ... Perspectives on universal health care ... Meet your 2021–22 APhA–ASP National Executive Committee ... Five ways you can help college-age students become #VaccineConfident ... A personal COVID-19 story ... Confidence will come ... Five tips for becoming a global pharmacist ... and more!

At APhA's Annual Meeting & Exposition in March, student pharmacists across the nation gathered virtually to engage in a weekend of sessions focused on leadership, advocacy, unconscious bias, networking, and more. Throughout the meeting, many student pharmacists shared inspiring stories of how their chapters have adapted to overcome the unique challenges of the COVID-19 pandemic.